Cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy: a systematic review and meta-analysis
D Patel, A Kumar, E Black-Maier… - Circulation …, 2021 - Am Heart Assoc
Background: Cardiac resynchronization therapy (CRT) represents a major medical advance
in patients with heart failure with electrical dyssynchrony to improve symptoms, reduce …
in patients with heart failure with electrical dyssynchrony to improve symptoms, reduce …
An updated meta-analysis of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy
F Liu, X Gao, J Luo - Frontiers in Cardiovascular Medicine, 2023 - frontiersin.org
Background Cardiac resynchronization therapy (CRT) is a major device therapy used to
treat patients suffering from heart failure (HF) and electrical asynchrony. It can improve HF …
treat patients suffering from heart failure (HF) and electrical asynchrony. It can improve HF …
Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy
F Leyva, A Zegard, F Umar, RJ Taylor, E Acquaye… - EP …, 2018 - academic.oup.com
Aims There is a continuing debate as to whether cardiac resynchronization therapy-
defibrillation (CRT-D) is superior to CRT-pacing (CRT-P), particularly in patients with non …
defibrillation (CRT-D) is superior to CRT-pacing (CRT-P), particularly in patients with non …
Outcomes of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy
F Leyva, A Zegard, E Acquaye, C Gubran… - Journal of the American …, 2017 - jacc.org
Background: Recent studies have cast doubt on the benefit of cardiac resynchronization
therapy (CRT) with defibrillation (CRT-D) versus pacing (CRT-P) for patients with …
therapy (CRT) with defibrillation (CRT-D) versus pacing (CRT-P) for patients with …
Is CRT-D superior to CRT-P in patients with nonischemic cardiomyopathy?
M Al-Sadawi, F Aslam, M Tao, S Salam… - International Journal of …, 2023 - Springer
Background Recent studies have questioned the role of implanted cardiac defibrillators
(ICDs) in nonischemic cardiomyopathy (NICM). Cardiac resynchronization therapy (CRT) …
(ICDs) in nonischemic cardiomyopathy (NICM). Cardiac resynchronization therapy (CRT) …
The benefits of defibrillator in heart failure patients with cardiac resynchronization therapy: A meta‐analysis
YX Long, Y Hu, DY Cui, S Hu… - Pacing and Clinical …, 2021 - Wiley Online Library
Background Current guidelines did not provide recommendations on indications of an
additional implantable cardioverter‐defibrillator (ICD) to patients receiving cardiac …
additional implantable cardioverter‐defibrillator (ICD) to patients receiving cardiac …
Efficacy of implantable cardioverter-defibrillator therapy in patients with nonischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled …
M Anantha Narayanan, K Vakil, YN Reddy… - JACC: Clinical …, 2017 - jacc.org
Objectives: This study sought to evaluate the efficacy of implantable cardioverter-defibrillator
(ICD) therapy with or without cardiac resynchronization therapy (CRT) in patients with …
(ICD) therapy with or without cardiac resynchronization therapy (CRT) in patients with …
Cardiac resynchronization therapy using pacemakers vs defibrillators in patients with nonischemic cardiomyopathy: the United States experience from 2007 to 2014
S Saba, T McLaughlin, M He, A Althouse, S Mulukutla… - Heart Rhythm, 2019 - Elsevier
Background The impact of implantable defibrillator therapy on outcomes of patients with
nonischemic cardiomyopathy (NICM) who receive a cardiac resynchronization therapy …
nonischemic cardiomyopathy (NICM) who receive a cardiac resynchronization therapy …
The addition of a defibrillator to resynchronization therapy decreases mortality in patients with nonischemic cardiomyopathy
Objectives The aim of this study was to determine whether patients with heart failure with
reduced ejection fraction (HFrEF) due to nonischemic etiology eligible for cardiac …
reduced ejection fraction (HFrEF) due to nonischemic etiology eligible for cardiac …
Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: a meta-analysis
Y Chen, C Duan, F Liu, S Shen, P Chen, J Bin - PLoS One, 2014 - journals.plos.org
Background Cardiac resynchronization therapy (CRT) has been extensively demonstrated
to benefit heart failure patients, but the role of underlying heart failure etiology in the …
to benefit heart failure patients, but the role of underlying heart failure etiology in the …
相关搜索
- meta analysis nonischemic cardiomyopathy
- defibrillation in patients nonischemic cardiomyopathy
- resynchronization therapy nonischemic cardiomyopathy
- resynchronization therapy meta analysis
- defibrillation in patients meta analysis
- resynchronization therapy defibrillators in patients
- resynchronization therapy impact of etiology
- meta analysis impact of etiology
- mortality in patients nonischemic cardiomyopathy
- resynchronization therapy mortality in patients
- cardioverter defibrillator nonischemic cardiomyopathy
- cardioverter defibrillator meta analysis